Literature DB >> 10809915

Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.

H Naver1, C Swartling, S M Aquilonius.   

Abstract

Focal hyperhidrosis is a common and sometimes handicapping condition for which the presently most effective treatment, sympathectomy, often leads to irreversible side-effects. We aimed to study effectiveness and tolerability of an alternative treatment with botulinum toxin injections over a period of one year for this condition. Twenty-eight patients with palmar (n = 19) and/or axillary (n = 13) hyperhidrosis were treated with intracutaneous injections of botulinum toxin (Botox(R)) 2 U/4 cm2. Sweat function was studied clinically and by objective measurements after treatment of one side. Treated and untreated sides, and pre- and post-treatment skin areas were compared. Subjective evaluation was performed after treatment of one side and 2-5 months after treatment of both sides. Duration of effect was controlled by a one-year follow-up. Sweating disappeared in eight out of 13 patients with axillary and in five out of 19 with palmar hyperhidrosis, and was reduced markedly in another five out of 13 and 10 out of 19 patients. Two-thirds of those treated for hand sweat noticed a slight and transient reduction of power of finger grip. No side-effects were noticed after treatment of axillary hyperhidrosis. We find intracutaneous injections of botulinum toxin with this technique safe and effective, and due to the relatively long duration of effect the treatment should be recommended before sympathectomy for focal hyperhidrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809915     DOI: 10.1046/j.1468-1331.2000.00014.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

1.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

Review 2.  Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors:  Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

Review 3.  [Botulinum toxin in focal hyperhidrosis. An update].

Authors:  C Hosp; M K Naumann; H Hamm
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

4.  Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics.

Authors:  Anna Karlsson-Groth; Alma Rystedt; Carl Swartling
Journal:  Clin Auton Res       Date:  2015-03-14       Impact factor: 4.435

5.  Topical 0.03% Atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: a randomized single blind controlled study.

Authors:  Ehsani Amirhoushang; Mirshams Shashahani Mostafa; Akhyani Maryam; Noormohamadpour Pardis; Noormohamadpour Pedram
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

6.  Results of thoracoscopic sympathectomy for the treatment of axillary and palmar hyperhidrosis with respect to compensatory hyperhidrosis and dry hands.

Authors:  M J Wilson; T R Magee; R B Galland; T C B Dehn
Journal:  Surg Endosc       Date:  2004-11-18       Impact factor: 4.584

Review 7.  Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety.

Authors:  Délia Szok; Anett Csáti; László Vécsei; János Tajti
Journal:  Toxins (Basel)       Date:  2015-07-17       Impact factor: 4.546

8.  A systematic evidence-based review of treatments for primary hyperhidrosis.

Authors:  Michael E Stuart; Sheri A Strite; Kristin Khalaf Gillard
Journal:  J Drug Assess       Date:  2020-12-24

9.  Treatment of primary axillary hyperhidrosis with botulinum toxin type a: our experience in 50 patients from 2007 to 2010.

Authors:  Stefano Scamoni; Luigi Valdatta; Claudia Frigo; Francesca Maggiulli; Mario Cherubino
Journal:  ISRN Dermatol       Date:  2012-10-17

10.  Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats.

Authors:  Matteo Runfola; Simone Rossi; Simona Panunzi; Pier Luigi Spada; Daniele Gui
Journal:  BMC Gastroenterol       Date:  2003-09-10       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.